Janisys is currently developing a novel active transdermal drug delivery system based on technology initially developed at Hewlett Packard. The device contains an array of wells containing high potent liquid formulations. Under wireless control, each well may be pre-programmed to deliver the liquid formulation at different times, transdermally, utilizing microneedles. The Company was spun out of Crospon